Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Cao Chao   Wang Jianmiao   Bunjhoo Hansvin   Xu Yongjian   Fang Huijuan  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Zhang Jian   Zhang Weiqing   Huang Shaohong   Li Hui   Li Yun   Chen Huiguo   Wu Weibing   Zhou Wei   Wang Cuiping   Liao Hongying   Gu Lijia  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-11 ,pp. : 849-858

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

By Jiang Jingwei   Huang Lizhen   Liang Xiaohua   Zhou Xinli   Huang Ruofan   Chu Zhaohui   Zhan Qiong  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

By Wei Shu-zhen  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 315-321

Humana Press, Inc

Access to resources Recommend Favorite

Effect of chemotherapy on quality of life in patients with non-small cell lung cancer

By Mannion Eileen   Gilmartin J.   Donnellan Paul   Keane Maccon   Waldron Dympna  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1417-1428

Springer Publishing Company

Access to resources Recommend Favorite